BIODEXA PHARMACEUTICALS-ADR (BDRX) Stock Analyst Earnings Estimates
NASDAQ:BDRX - Nasdaq - US59564R8079 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 578K 68.51% | 699K 20.93% | 381K -45.49% | -100.00% | 3.067K | |||
| EBITDA YoY % growth | -6.595M 30.24% | -8.589M -30.24% | -7.731M 9.99% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.998M 34.42% | -8.932M -27.64% | -8.014M 10.28% | -11.249M -40.36% | -13.779M -22.49% | -20.335M -47.58% | -20.893M -2.74% | |
| Operating Margin | -1,210.73% | -1,277.83% | -2,103.41% | N/A | N/A | N/A | -681,199.99% | |
| EPS YoY % growth | N/A | N/A | N/A | -3.92 80.32% | -2.61 33.34% | -2.94 -12.51% | -2.30 21.72% |
All data in GBP
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in GBP
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 83K -64.07% | % | ||
| Q2 2023 Q2Q % growth | 298K -36.32% | % | ||
| Q4 2022 Q2Q % growth | 231K 30.51% | % | ||
| Q2 2022 Q2Q % growth | 468K 16.71% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | -100% |